Clinical trial
Cardiovascular-Renal Consequences of Reducing Renal Mass After Living Kidney Donation
NCT01564966 is registered in ClinicalTrials.gov with Istanbul University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiovascular-Renal Consequences of Reducing Renal Mass After Living Kidney Donation
- Lead sponsor
- Istanbul University
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2008
- Completion date
- December 31, 2011
- Enrollment
- 46 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
albuminuria, endothelial dysfunction, hypertension, inflammation, kidney failure, renal failure